John L. Higgins
2012
In 2012, John L. Higgins earned a total compensation of $2.4M as President and Chief Executive Officer at Ligand Pharmaceuticals, a 45% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $363,388 |
|---|---|
| Option Awards | $1,433,896 |
| Salary | $484,517 |
| Stock Awards | $86,820 |
| Other | $2,715 |
| Total | $2,371,336 |
Higgins received $1.4M in option awards, accounting for 60% of the total pay in 2012.
Higgins also received $363.4K in non-equity incentive plan, $484.5K in salary, $86.8K in stock awards and $2.7K in other compensation.
Rankings
In 2012, John L. Higgins' compensation ranked 2,981st out of 11,487 executives tracked by ExecPay. In other words, Higgins earned more than 74.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,981 out of 11,487 | 74th |
Division Manufacturing | 1,045 out of 4,253 | 75th |
Major group Chemicals And Allied Products | 237 out of 1,203 | 80th |
Industry group Drugs | 139 out of 925 | 85th |
Industry Pharmaceutical Preparations | 112 out of 700 | 84th |
Source: SEC filing on March 12, 2015.
Higgins' colleagues
We found four more compensation records of executives who worked with John L. Higgins at Ligand Pharmaceuticals in 2012.